Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$1.48B |
| 2 |
NVIDIA
NVDA
|
+$782M |
| 3 |
Amazon
AMZN
|
+$657M |
| 4 |
Walt Disney
DIS
|
+$572M |
| 5 |
Advanced Micro Devices
AMD
|
+$517M |
Top Sells
| 1 |
ATVI
Activision Blizzard Inc.
ATVI
|
+$1.41B |
| 2 |
Palo Alto Networks
PANW
|
+$708M |
| 3 |
Boston Scientific
BSX
|
+$704M |
| 4 |
Comcast
CMCSA
|
+$673M |
| 5 |
T-Mobile US
TMUS
|
+$625M |
Sector Composition
| 1 | Technology | 19.27% |
| 2 | Healthcare | 14.85% |
| 3 | Financials | 10.95% |
| 4 | Consumer Discretionary | 10.86% |
| 5 | Industrials | 7.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
5101
Exagen
XGN
$214M
| $41.3K | ﹤0.01% |
+20,735
| New | +$41.3K |
|
5102
Cardiff Oncology
CRDF
$136M
| $41.1K | ﹤0.01% |
+27,760
| New | +$41.1K |
|
|
XELA
5103
DELISTED
Exela Technologies, Inc. Common Stock
XELA
| $41.1K | ﹤0.01% |
+12,227
| New | +$41.1K |
|
5104
Ametek
AME
$43.9B
| $40.9K | ﹤0.01% |
248
-204,830
| -100% | -$33.8M |
|
|
RNLX
5105
DELISTED
Renalytix plc American Depositary Shares
RNLX
| $40.7K | ﹤0.01% |
+104,392
| New | +$40.7K |
|
5106
WM Technology
MAPS
$131M
| $40.7K | ﹤0.01% |
+56,454
| New | +$40.7K |
|
5107
Select Water Solutions
WTTR
$946M
| $40.3K | ﹤0.01% |
5,303
-95,728
| -95% | -$727K |
|
|
CTHR
5108
DELISTED
Charles & Colvard Ltd
CTHR
| $40.2K | ﹤0.01% |
9,805
+5,005
| +104% | +$20.5K |
|
5109
Scienjoy Holding
SJ
$30.8M
| $40K | ﹤0.01% |
+11,508
| New | +$40K |
|
|
SBDS
5110
Solo Brands, Inc.
SBDS
$26M
| $39.9K | ﹤0.01% |
6,473
-169,433
| -96% | -$1.04M |
|
5111
Compugen
CGEN
$125M
| $39.5K | ﹤0.01% |
+19,943
| New | +$39.5K |
|
5112
Marchex
MCHX
$86.4M
| $39.3K | ﹤0.01% |
28,913
+6,694
| +30% | +$9.1K |
|
5113
urban-gro
UGRO
$7.48M
| $39.3K | ﹤0.01% |
+28,052
| New | +$39.3K |
|
|
PFIE
5114
DELISTED
Profire Energy, Inc
PFIE
| $39.2K | ﹤0.01% |
+21,642
| New | +$39.2K |
|
5115
Society Pass
SOPA
$7.27M
| $39.2K | ﹤0.01% |
8,449
+6,414
| +315% | +$29.7K |
|
5116
RE/MAX Holdings
RMAX
$195M
| $38.9K | ﹤0.01% |
2,917
-60,291
| -95% | -$804K |
|
5117
Lisata Therapeutics
LSTA
$19.2M
| $38.6K | ﹤0.01% |
14,131
-4,451
| -24% | -$12.2K |
|
5118
Mainz Biomed
MYNZ
$7.6M
| $38.6K | ﹤0.01% |
+831
| New | +$38.6K |
|
5119
Reading International Class A
RDI
$33.8M
| $38.5K | ﹤0.01% |
20,167
+2,569
| +15% | +$4.91K |
|
|
CEI
5120
DELISTED
Camber Energy, Inc
CEI
| $38.1K | ﹤0.01% |
+166,640
| New | +$38.1K |
|
5121
POET Technologies
POET
$475M
| $38.1K | ﹤0.01% |
+40,684
| New | +$38.1K |
|
5122
DLH Holdings
DLHC
$79.1M
| $38K | ﹤0.01% |
2,415
-4,733
| -66% | -$74.5K |
|
|
BLRX
5123
BioLineRX
BLRX
$17.2M
| $38K | ﹤0.01% |
605
-869
| -59% | -$54.6K |
|
5124
SPDR Portfolio S&P 600 Small Cap ETF
SPSM
$12.7B
| $38K | ﹤0.01% |
900
-59,331
| -99% | -$2.5M |
|
|
FENG
5125
Phoenix New Media
FENG
$30.7M
| $37.8K | ﹤0.01% |
27,778
-31,744
| -53% | -$43.2K |
|